GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, KIT, MET, SLC1A1, SLC6A2, SLC6A3, SRC, TNKS, TNKS2, XDH |
10.574 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, FABP3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, SLC6A3, SRC, TYR |
10.4105 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, SLC6A3, SRC, TYR |
10.3324 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, SLC6A2, SLC6A3, SRC, TYR |
9.54468 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.44334 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, FLT3, HSD11B2, SLC6A3, SRC, TYR |
9.12426 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.27706 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MMP9, SLC6A3, SRC |
8.14981 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET |
7.96839 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
7.92178 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, SRC, TYR |
7.42303 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT |
7.42303 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, APP, CA2, CA7, DRD2, DRD3, DRD4, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT |
7.42303 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.34669 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
7.03823 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
7.02109 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, GBA2, SLC6A3, TYR |
6.902 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.82396 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRB, F3, FABP4, GRM1, GRM5, GRM8, HSD11B2, HSD17B2, IGF1R, KIT, MET, MMP1, MMP2, MMP9, PIM1, SLC6A2, SLC6A3, SRC, TNKS2, TYR |
6.72257 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA3, AKR1B1, AKR1C3, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PIM1, SRC, XDH |
6.39993 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
6.33699 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GRM5, HSD11B2, IGF1R, KIT, MMP2, SRC |
6.32949 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC1A1, SLC6A3, SRC, TNKS, TNKS2, XDH |
6.25806 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F3, FLT3, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
6.25806 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
6.11943 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.97679 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.82866 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, FABP3, HSD11B2, KDR, SLC6A2, SLC6A3, SRC |
5.74589 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.6961 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, F3, FLT3, GRM1, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.6961 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
5.62421 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, KIT, SRC |
5.54429 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, IGF1R, KDR, KIT, MMP2, MMP9, PIM1 |
5.53972 |
[BP] GO:0007193 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
5.43522 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD2, DRD3, DRD4, SLC6A3, TYR |
5.3645 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MMP9, SLC6A3 |
5.28268 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, KDR, SLC6A3, SRC |
5.28268 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, KIT, SRC, TYR |
5.27683 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, CSNK2A1, DRD2, DRD3, DRD4, SLC6A3 |
5.26985 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, KIT, MMP2, MMP9, SRC |
5.20522 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.17856 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, SLC1A1 |
5.1429 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, KDR, KIT, MMP2, SRC |
5.1429 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, F3, FLT3, GRM1, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, XDH |
5.11449 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, TYR, XDH |
5.05569 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, DRD2, DRD4, F3, FLT3, GRM1, KDR, KIT, MET, PTPN1, SRC, XDH |
5.03339 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESRRA, F3, FABP4, FLT3, GRM1, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.03339 |
[BP] GO:0007165 |
signal transduction
|
ADORA3, AKR1B1, AKR1C3, APP, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2 |
4.92088 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GBA2, PIM1, TYR, XDH |
4.92088 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, DRD2, DRD3, F3, KIT, MET, SRC, XDH |
4.82407 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA3, AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, PTPN1, SLC6A2, SLC6A3, SRC, TYR |
4.80735 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PTPN1, SRC, TNKS |
4.74867 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PIM1, SLC6A3, SRC, TNKS2, TYR |
4.52924 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, MET |
4.52924 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, MET, SRC |
4.51601 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, SLC6A3, TNKS2 |
4.49108 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, XDH |
4.47933 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.46026 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.37929 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.37929 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, TYR, XDH |
4.3013 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
APP, BCL2, CDC25B, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
4.25845 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD2, DRD3, DRD4, GRIK5, SLC1A1, SLC6A2, SLC6A3 |
4.24591 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.24589 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
APP, BCL2, CDC25B, DRD2, DRD3, DRD4, ESRRB, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
4.21452 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, IGF1R, KDR, KIT, MMP2, MMP9, PTPN1, SRC |
4.20856 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, KIT, MMP9, PIM1, SLC6A3, SRC, TYR |
4.20856 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.20856 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, SLC6A3, SRC, TYR |
4.19973 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD2, DRD3, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
4.1611 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
4.14017 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, SLC1A1 |
4.14017 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.09669 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD2, DRD3, DRD4, SLC6A3 |
4.09669 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.09429 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3, GBA2 |
4.08806 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, XDH |
4.06904 |
[BP] GO:0030818 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
4.06625 |
[BP] GO:0030803 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.97946 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, KIT, SRC |
3.95057 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
3.95057 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CDK6, DRD2, DRD3, KDR, SRC, TNKS, TNKS2 |
3.90822 |
[BP] GO:0030815 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.90822 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD2, DRD3, DRD4, FABP3, FLT3, GRM5, HSD11B2, IGF1R, MMP2, SLC6A3, SRC, TYR |
3.88797 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
3.88454 |
[BP] GO:0007268 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.88454 |
[BP] GO:0098916 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.88454 |
[BP] GO:1900372 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.88454 |
[BP] GO:0030809 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.88454 |
[BP] GO:0030800 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.84349 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
APP, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.84074 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
APP, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP3, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.84074 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP3, FABP4, FUT7, GBA2, KIT, MET |
3.84074 |
[BP] GO:0099536 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.82431 |
[BP] GO:0099537 |
None
|
DRD2, DRD3, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.82431 |
[BP] GO:0007188 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
3.73524 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GRM1, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SLC6A3, SRC, TNKS, TNKS2, XDH |
3.73524 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
APP, BCL2, CDC25B, DRD2, DRD4, ESRRB, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.7349 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
AKR1C3, APP, AURKB, BCL2, CDC25B, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.7102 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.67706 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, KIT, MMP9, PTPN1, SRC, TNKS, XDH |
3.65809 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, DRD4, FABP3, GRIA2, GRIA4, GRIK5, SLC1A1, SLC6A2, SLC6A3 |
3.62367 |
[BP] GO:0048169 |
None
|
APP, DRD2, GRM5, KIT |
3.61488 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
AKR1C3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GRM1, GRM5, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.6118 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APP, AXL, CDK6, CYP1B1, ESR1, GRIK5, GRM5, IGF1R, MMP2, MMP9, SRC |
3.6118 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, XDH |
3.603 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.56303 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
DRD2, GRM1, GRM3, GRM5, GRM8 |
3.56303 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.56303 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
3.55903 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
3.53793 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
3.51981 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.51981 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.51981 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.51981 |
[BP] GO:0051940 |
None
|
DRD2, DRD3, DRD4 |
3.51981 |
[BP] GO:0051584 |
None
|
DRD2, DRD3, DRD4 |
3.51981 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.51981 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, AXL, BCL2, CYP1B1, MMP9, SRC |
3.49449 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MMP1, MMP2, MMP9, SLC6A3, SRC, XDH |
3.49215 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, AKR1C3, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GRIK5, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC, XDH |
3.48316 |
[BP] GO:0042417 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.4717 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, KIT, MMP2, MMP9, SRC |
3.4516 |
[BP] GO:0007626 |
None
|
APP, DRD2, DRD3, DRD4, GRM1, GRM5, SLC6A3 |
3.42876 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, FABP3, GRM1, GRM5 |
3.42675 |
[BP] GO:0007187 |
None
|
DRD2, DRD3, DRD4, GRM1, GRM3, GRM5, GRM8 |
3.37385 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.37385 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.33387 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
APP, BCL2, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.33008 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2, SLC6A3 |
3.3142 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA3, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, F3, GRIK5, GRM5, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC |
3.29797 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.29797 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, BCL2, CYP19A1, ESR1, HSD17B2, KIT, SRC |
3.28924 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.28924 |
[BP] GO:0007194 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.26965 |
[BP] GO:0007195 |
None
|
DRD2, DRD3, DRD4 |
3.2519 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.2519 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.2519 |
[BP] GO:1900543 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.2519 |
[BP] GO:0044093 |
positive regulation of molecular function
|
APP, AURKB, BCL2, CDC25B, DRD2, DRD4, ESR1, ESR2, F3, FLT3, GRM1, GRM5, KIT, MET, MMP9, PTPN1, SRC, TNKS, XDH |
3.25144 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRM1, GRM5, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.23976 |
[BP] GO:0045980 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
3.22887 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DRD2, DRD3, DRD4, ESR1, F3, FLT3, FUT7, GBA2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, TYR, XDH |
3.20117 |
[BP] GO:0031280 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.18734 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F3, FLT3, GRM1, IGF1R, KDR, KIT, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
3.18471 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, KIT, SRC |
3.14728 |
[BP] GO:0034776 |
None
|
DRD2, DRD3, DRD4 |
3.14015 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.14015 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, FLT3, IGF1R, KDR, KIT, MET, PIM1, PTPN1, SRC, TNKS, XDH |
3.12982 |
[BP] GO:0060078 |
None
|
DRD4, GRIA2, GRIA4, GRIK5, GRM5 |
3.10754 |
[BP] GO:0051350 |
None
|
DRD2, DRD3, DRD4, GRM3 |
3.10146 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD2, DRD3, GRM1, HSD11B2, KIT, MMP2, SRC, TYR |
3.0986 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
3.08649 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, DRD2, DRD3, KDR, SRC |
3.0825 |
[BP] GO:0007154 |
None
|
AKR1C3, AXL, BCL2, DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
3.0825 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC |
3.0825 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.06995 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
3.06995 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GRM3, GRM8, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, XDH |
3.06116 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KIT, PTPN1, SRC, TNKS |
3.05797 |
[BP] GO:0042391 |
None
|
APP, BCL2, DRD4, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.00577 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
APP, DRD2, DRD4, FLT3, GRM1, KDR, KIT, PTPN1, SRC, XDH |
2.99044 |
[BP] GO:0042325 |
regulation of phosphorylation
|
APP, BCL2, CDC25B, DRD2, DRD4, ESRRB, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.95963 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, BCL2, CA2, FLT3, HSD11B2, SRC |
2.95963 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
2.95254 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, F3, FABP4, FLT3, GRM1, GRM3, GRM5, IGF1R, KIT, MET, MMP9, PIM1, PTPN1, SRC, TNKS, XDH |
2.95008 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.95008 |
[BP] GO:0060134 |
None
|
DRD2, DRD3, SLC6A3 |
2.95008 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.93848 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.93848 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.93848 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.93848 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.93848 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, TYR, XDH |
2.93527 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.93527 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD2, DRD3, TNKS, TNKS2 |
2.90063 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, FLT3, IGF1R, KDR, KIT, MET, PIM1, PTPN1, SRC, TNKS, XDH |
2.89948 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, KDR, KIT, MET, MMP9, PIM1, SLC1A1, SLC6A3, SRC |
2.88155 |
[BP] GO:0022898 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.88155 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.88119 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.88119 |
[BP] GO:0051580 |
None
|
DRD2, DRD3, DRD4 |
2.88119 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, KIT, MET, PIM1, SRC, TYR |
2.87732 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F3, KIT, MET, SRC |
2.87692 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.87029 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
APP, BCL2, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.86524 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KIT, PTPN1, SRC |
2.8538 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCL2, FLT3, HSD11B2, SRC |
2.83774 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA3, APP, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, GRM1, KDR, KIT, MET, MMP9, PIM1, SLC1A1, SLC6A3, SRC, TNKS2, XDH |
2.81479 |
[BP] GO:0045761 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.8051 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
2.76452 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA3, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TNKS, TNKS2, XDH |
2.75581 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SRC |
2.7508 |
[BP] GO:0032409 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.7508 |
[BP] GO:0003014 |
None
|
AKR1B1, AKR1C3, BCL2, DRD2, HSD11B2 |
2.74653 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
2.74272 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.73327 |
[BP] GO:0032225 |
None
|
DRD2, DRD3, DRD4 |
2.73327 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
APP, AURKB, BCL2, CDC25B, DRD2, DRD4, ESR1, F3, FLT3, GRM1, GRM5, KIT, PTPN1, SRC, TNKS, XDH |
2.73327 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1 |
2.73327 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
AURKB, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KIT, PTPN1, SRC, TNKS |
2.73008 |
[BP] GO:0030817 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.71507 |
[BP] GO:0008542 |
None
|
APP, DRD2, DRD3, KIT |
2.71493 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, MMP9, SRC |
2.69907 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.69554 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.66705 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC6A2, SLC6A3 |
2.66705 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
2.64525 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
APP, BCL2, CDC25B, CSNK2A1, DRD2, DRD4, ESR1, F3, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.64525 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APP, CYP1A1, CYP1B1, ESR1, FLT3, SRC |
2.64079 |
[BP] GO:0048168 |
None
|
APP, DRD2, GRM5, KIT |
2.62611 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.62004 |
[BP] GO:0044242 |
None
|
AKR1B10, AKR1C3, CYP1B1, FABP3, FABP4, GBA2 |
2.61728 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1 |
2.6133 |
[BP] GO:0043549 |
regulation of kinase activity
|
APP, CDC25B, DRD2, DRD4, FABP4, FLT3, GRM1, GRM5, IGF1R, KIT, PTPN1, SRC |
2.59642 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, SRC |
2.59402 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
APP, DRD2, DRD4, FLT3, GRM1, IGF1R, KDR, KIT, PTPN1, SRC, XDH |
2.57449 |
[BP] GO:0007632 |
None
|
APP, DRD2, DRD3, KIT |
2.57449 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.57449 |
[BP] GO:0015909 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.57449 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
2.57449 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.57449 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.57449 |
[BP] GO:0051944 |
None
|
DRD2, DRD4 |
2.57449 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.57449 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.57449 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.57449 |
[BP] GO:0051586 |
None
|
DRD2, DRD4 |
2.57449 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.57449 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.5667 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, KIT |
2.5667 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.56583 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.5649 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9 |
2.51044 |
[BP] GO:0048148 |
None
|
DRD2, DRD3, DRD4 |
2.49976 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F3, IGF1R, KDR, KIT, MET, MMP9, SRC |
2.48402 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, XDH |
2.46021 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AXL, BCL2, CDC25B, CDK6, CYP1A1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, KIT, MET, MMP2, MMP9, SRC |
2.45631 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.44337 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.44107 |
[BP] GO:0030814 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.4368 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.43359 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, DRD2, DRD3, DRD4, KIT, MMP9, SLC1A1, SLC6A3, XDH |
2.42856 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
APP, BCL2, CDC25B, DRD2, DRD4, ESR1, F3, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.42365 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
2.42215 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.41117 |
[BP] GO:0007267 |
None
|
DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.40658 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, AXL, CYP1B1, MMP9, SRC |
2.40459 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD2, DRD3, KIT, TYR |
2.40187 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
APP, BCL2, CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.40187 |
[BP] GO:0030802 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.40187 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.40187 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.39933 |
[BP] GO:0031279 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.39439 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.37653 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
APP, CA2, CA7, DRD2, DRD4 |
2.37553 |
[BP] GO:0051339 |
None
|
DRD2, DRD3, DRD4, GRM3 |
2.37326 |
[BP] GO:0003008 |
None
|
AKR1B1, AKR1C3, APP, BCL2, CYP1B1, DRD2, DRD3, GRM1, GRM5, GRM8, HSD11B2, KIT, SLC6A3, SRC, TYR |
2.36562 |
[BP] GO:1903963 |
None
|
DRD2, DRD3, DRD4 |
2.35701 |
[BP] GO:0050482 |
None
|
DRD2, DRD3, DRD4 |
2.35701 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.35701 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KIT, PTPN1, SRC |
2.35548 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
2.3541 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.35394 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.34606 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.34606 |
[BP] GO:0051582 |
None
|
DRD2, DRD4 |
2.34606 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.34606 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.34108 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.33304 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31673 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, SRC |
2.31513 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, BCL2, CA2, CA7, DRD2, DRD3, DRD4, ESR1, GRIK5, GRM1, GRM5 |
2.31513 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, DRD3, ESR1, ESR2, GRIK5, IGF1R, KDR, KIT, MET, MMP1, MMP9, PTPN1, SRC, TNKS, TNKS2 |
2.29701 |
[BP] GO:1900371 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.27692 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, DRD4, FABP3 |
2.27425 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, SRC |
2.26474 |
[BP] GO:0030808 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.26474 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.25274 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
AKR1C3, APP, AURKB, BCL2, CSNK2A1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, FABP4, GRM3, GRM8, IGF1R, KDR, MET, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
2.23708 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, DRD2, DRD3, DRD4, ESR1, GRM1, GRM5 |
2.2328 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TNKS, TNKS2, TYR, XDH |
2.2328 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1 |
2.2328 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.23095 |
[BP] GO:0032309 |
None
|
DRD2, DRD3, DRD4 |
2.23095 |
[BP] GO:0001975 |
None
|
DRD2, DRD3, DRD4 |
2.23095 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD2, DRD3, DRD4, GRM1, GRM5, KIT, SLC6A3 |
2.22929 |
[BP] GO:0048638 |
regulation of developmental growth
|
APP, BCL2, DRD2, DRD3, PIM1, SLC6A3, TNKS2 |
2.2256 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
2.20732 |
[BP] GO:0008306 |
None
|
APP, DRD2, DRD3, KIT |
2.19508 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, XDH |
2.19151 |
[BP] GO:0007612 |
None
|
APP, DRD2, DRD3, GRM5, KIT |
2.19151 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.19151 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.19151 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
CDC25B, DRD2, DRD4, FLT3, GRM1, GRM5, KIT, PTPN1, SRC |
2.19148 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.17841 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APP, ESR1, FLT3, GRM5, IGF1R, KIT, MMP2, SRC |
2.17436 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.17436 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.17436 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.17436 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.17436 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.17436 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.17436 |
[BP] GO:0032412 |
None
|
APP, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.16786 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCL2, CYP1A1, HSD11B2, SRC, TYR |
2.16611 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, FABP3, HSD17B2, KDR, MMP2, SRC |
2.15733 |
[BP] GO:0043271 |
negative regulation of ion transport
|
BCL2, DRD2, DRD3, DRD4, MMP9 |
2.13827 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.12646 |
[BP] GO:0030799 |
None
|
DRD2, DRD3, DRD4, GRM3, GRM8 |
2.12609 |
[BP] GO:0034762 |
None
|
APP, BCL2, CA2, DRD2, DRD3, DRD4, GRM5, MMP9 |
2.12488 |
[BP] GO:0071715 |
None
|
DRD2, DRD3, DRD4 |
2.12198 |
[BP] GO:1901571 |
None
|
DRD2, DRD3, DRD4 |
2.12198 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB |
2.11732 |
[BP] GO:0023052 |
None
|
DRD2, DRD3, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, SLC6A2 |
2.11721 |
[BP] GO:0022602 |
ovulation cycle process
|
BCL2, ESR1, KIT, SRC |
2.11295 |
[BP] GO:0032845 |
None
|
BCL2, DRD2, SRC, TNKS, TNKS2 |
2.10642 |
[BP] GO:0046717 |
None
|
DRD2, DRD3, DRD4, SLC1A1 |
2.09418 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.09418 |
[BP] GO:0050730 |
None
|
APP, FLT3, GRM5, KIT, PTPN1, SRC |
2.09252 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.08925 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.08925 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC |
2.08925 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.08925 |
[BP] GO:0032204 |
None
|
AURKB, SRC, TNKS, TNKS2 |
2.07891 |
[BP] GO:1900542 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8 |
2.0685 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, PIM1, PTPN1, SRC |
2.06256 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9 |
2.06256 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.06174 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
AKR1C3, CYP1A2, MMP9 |
2.05672 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, SLC6A3 |
2.05672 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.05672 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
DRD4, FLT3, GRM1, IGF1R, KIT, PTPN1, SRC |
2.05052 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.05052 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.05052 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.05052 |
[BP] GO:0032415 |
None
|
DRD3, DRD4 |
2.05052 |
[BP] GO:0051934 |
None
|
SLC6A2, SLC6A3 |
2.05052 |
[BP] GO:0021984 |
None
|
DRD2, SLC6A3 |
2.05052 |
[BP] GO:0090494 |
None
|
SLC6A2, SLC6A3 |
2.05052 |
[BP] GO:0090493 |
None
|
SLC6A2, SLC6A3 |
2.05052 |
[BP] GO:0051583 |
None
|
SLC6A2, SLC6A3 |
2.05052 |
[BP] GO:0016115 |
None
|
AKR1B10, AKR1C3 |
2.05052 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, DRD3, TNKS |
2.05049 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, SRC, TNKS |
2.0371 |
[BP] GO:0040018 |
None
|
BCL2, DRD2, SLC6A3 |
2.03549 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
CA2, CA7, DRD2 |
2.03549 |
[BP] GO:0006140 |
None
|
DRD2, DRD3, DRD4, ESRRB, GRM3, GRM8 |
2.02897 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA3, AKR1C3, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP9, PIM1, PTPN1, SLC6A3, SRC, TNKS, TNKS2, XDH |
2.01556 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.00849 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, DRD4, MMP9 |
2.00849 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, PTPN1, XDH |
2.00593 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1 |
2.00309 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DRD4, FABP4, GRM3, GRM8, IGF1R, PTPN1, XDH |
2.00309 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC |
2.00309 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, HSD11B2, IGF1R, SRC |
2.0019 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD2, DRD3, DRD4, ESR1, F3, FLT3, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC |
4.91495 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA3, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TNKS, TNKS2, TYR |
4.74867 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA3, APP, AXL, CA4, DRD2, DRD3, DRD4, F3, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
4.68592 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA3, APP, AXL, CA2, CA4, CA9, DRD2, DRD3, DRD4, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET, SLC1A1, SLC6A2, SLC6A3, SRC |
4.1176 |
[CC] GO:0044456 |
None
|
ACHE, APP, DRD2, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SLC6A3, SRC |
3.90822 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA3, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, F3, FLT3, FUT7, GBA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MET, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TYR |
3.81885 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA3, APP, AXL, DRD2, DRD3, DRD4, FLT3, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, SLC1A1, SLC6A2, SLC6A3 |
3.81298 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.49215 |
[CC] GO:0098590 |
plasma membrane region
|
CA2, CA4, CA9, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
3.20117 |
[CC] GO:0098794 |
None
|
APP, DRD2, DRD4, GRIA2, GRIA4, GRM3 |
2.87692 |
[CC] GO:0043005 |
None
|
APP, CA2, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.83741 |
[CC] GO:0043197 |
None
|
APP, DRD2, GRIA2, GRIA4, GRM3 |
2.41117 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.39002 |
[CC] GO:0044309 |
None
|
APP, DRD2, GRIA2, GRIA4, GRM3 |
2.39002 |
[CC] GO:0014069 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.37298 |
[CC] GO:0099572 |
None
|
DRD2, GRIK5, GRM1, GRM3, GRM5, SRC |
2.37298 |
[CC] GO:0042995 |
cell projection
|
AKR1B1, APP, CA2, CDK6, DRD2, DRD3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.37142 |
[CC] GO:0120025 |
None
|
AKR1B1, APP, CA2, CDK6, DRD2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, SLC6A2, SLC6A3, SRC |
2.12488 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.05052 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PTPN1, TNKS, TYR, XDH |
10.4105 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.9211 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.13783 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, SRC, TNKS, TNKS2, TYR, XDH |
8.11057 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET |
6.31765 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.24776 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.15992 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, KIT, MET, MMP1, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TYR, XDH |
6.01711 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA3, AXL, CDK6, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET |
5.95444 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, KIT, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, TNKS, TNKS2, TYR, XDH |
5.82866 |
[MF] GO:0030594 |
None
|
DRD2, DRD3, DRD4, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
5.6813 |
[MF] GO:0004872 |
receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET |
5.54429 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.46666 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
5.08223 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.9383 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET |
4.92551 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.81312 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.66131 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PTPN1, TNKS |
4.57387 |
[MF] GO:0035240 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
4.57183 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET |
4.36889 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA3, AXL, DRD2, DRD3, DRD4, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, KIT, MET |
4.36889 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.33984 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.14947 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.06625 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, KIT, MMP1, MMP2, MMP9, PIM1, PTPN1, SLC1A1, SLC6A2, SLC6A3, TNKS, TNKS2, TYR, XDH |
4.0126 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1 |
3.98011 |
[MF] GO:1901338 |
None
|
DRD2, DRD3, DRD4, SLC6A3 |
3.9268 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD2, DRD3, DRD4, FLT3, IGF1R, KDR, KIT, MET, PIM1, SLC6A3, SRC |
3.81282 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.80701 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.73908 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.67654 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.56303 |
[MF] GO:0001591 |
None
|
DRD2, DRD3, DRD4 |
3.51981 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.40197 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.36239 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD2, DRD3, DRD4, SLC6A3 |
3.20154 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, DRD4, ESR1, ESR2, FLT3, GRIK5, IGF1R, KDR, KIT, MET, MMP9, TYR, XDH |
3.0986 |
[MF] GO:0004952 |
None
|
DRD2, DRD3, DRD4 |
3.04656 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.93848 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.93848 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.93848 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.88119 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.83774 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.8051 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB |
2.68573 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.68573 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.57449 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A3 |
2.57449 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.57449 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.5667 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5649 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.5649 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B2, HSD17B1, SRC, XDH |
2.51433 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB |
2.43359 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.34606 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.34606 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.32123 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.29169 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.23095 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1 |
2.19794 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.17436 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.17436 |
[MF] GO:0051721 |
None
|
BCL2, PTPN1, SLC6A3 |
2.15941 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.05672 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.05672 |
[MF] GO:0005329 |
None
|
SLC6A2, SLC6A3 |
2.05052 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.05052 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.05052 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2 |
2.05052 |